MARC Record from marc_columbia

LEADER: 02335cam a2200469 a 4500
001 3923716
005 20221027002240.0
008 860210s1982 ne a b 101 0 eng
010 $a 83164912
020 $a0444903194 (Elsevier Science)
035 $a(OCoLC)9476562
035 $a(OCoLC)ocm09476562
035 $a(CStRLIN)NYCM86-B412
035 $9ADH6286HS
035 $a(NNC)3923716
035 $a3923716
040 $dCStRLIN$dNNC-M
041 0 $aeng$bfregeritaspa
050 00 $aRC821$b.R36 1982
082 0 $a616.3/43061$219
245 00 $aRanitidine :$bproceedings of an international symposium held in the context of the Seventh World Congress of Gastroenterology, Stockholm, 17th June 1982 /$ceditors, A.J. Riley and P.R. Salmon.
260 $aAmsterdam ;$aPrinceton :$bExcerpta Medica ;$aNew York, NY, USA ;$aSole distributors for the USA, Elsevier Science Pub. Co.,$c1982.
300 $aix, 227 pages, 43 unnumbered pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aCurrent clinical practice series ;$vno. 1
500 $aSummaries in French, German, Italian, and Spanish.
500 $aProceedings of the Third International Symposium on Ranitidine, sponsored by Glaxo Group Research Laboratories.
504 $aIncludes bibliographical references and index.
650 0 $aPeptic ulcer$xChemotherapy$vCongresses.
650 0 $aRanitidine$xTesting$vCongresses.
650 0 $aRanitidine$xPhysiological effect$vCongresses.
650 2 $aRanitidine.$0https://id.nlm.nih.gov/mesh/D011899
650 2 $aPeptic Ulcer$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D010437Q000188
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aRiley, A.$0http://id.loc.gov/authorities/names/n82023721
700 1 $aSalmon, P. R.$q(Paul Raymond)$0http://id.loc.gov/authorities/names/n83204893
711 2 $aSymposium on Malotilate$d(1982 :$cStockholm, Sweden)$0http://id.loc.gov/authorities/names/n86810200
711 2 $aInternational Symposium on Ranitidine$n(3rd :$d1982 :$cStockholm, Sweden)
710 2 $aGlaxo Group Research Limited.$0http://id.loc.gov/authorities/names/n83204892
830 0 $aCurrent clinical practice series ;$v1.$0http://id.loc.gov/authorities/names/n83742000
852 00 $boff,hsl$hRC821$i.R36 1982